Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Juliet E Wolford"'
Publikováno v:
Current Oncology Reports. 24:889-904
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9f68a20f1a00667ca2bee0119757bca
https://doi.org/10.1007/s11912-021-01163-2
https://doi.org/10.1007/s11912-021-01163-2
Autor:
Bradley J. Monk, Jiaru Bai, Kathleen N. Moore, Krishnansu S. Tewari, Rebecca Kristeleit, Juliet E Wolford
Publikováno v:
Gynecol Oncol
Background Olaparib was approved on December 19, 2014 by the US FDA as 4th-line therapy (and beyond) for patients with germline BRCA1/2 mutations; rucaparib was approved on December 19, 2016 as 3rd-line therapy (and beyond) for germline or somatic BR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7445d34acdb8341bb130e8f230fe58
https://doi.org/10.1016/j.ygyno.2020.02.030
https://doi.org/10.1016/j.ygyno.2020.02.030
Publikováno v:
Expert Review of Molecular Diagnostics. 20:285-292
Introduction: Poly(ADP-ribose) polymerase (PARP) inhibitors, including rucaparib, are the only targeted class of therapeutics approved for recurrent epithelial ovarian carcinoma with a predictive biomarker. Currently, three different PARP inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae57477267355524f807a748a6cd4f49
https://doi.org/10.1080/14737159.2020.1701438
https://doi.org/10.1080/14737159.2020.1701438
Publikováno v:
Current oncology reportsPapers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance. 24(7)
The treatment of patients with advanced gynecologic malignancies remains challenging. Advancements in genomics have led to recognition and development of individualized therapeutic targets. This article reviews the current trends in precision medicin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8c99fff149944418b09a8bb5f857d28
https://pubmed.ncbi.nlm.nih.gov/35347591
https://pubmed.ncbi.nlm.nih.gov/35347591
Publikováno v:
Current opinion in obstetricsgynecology. 32(1)
A significant number of women diagnosed with a gynecologic malignancy meet criteria for fertility-sparing treatment. Women are continuing to delay childbearing; the importance of fertility-sparing therapy is, therefore, increasing. It is imperative t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbdb312879e84bcb9da1af0e0318738d
https://pubmed.ncbi.nlm.nih.gov/31851046
https://pubmed.ncbi.nlm.nih.gov/31851046
Publikováno v:
Current opinion in obstetricsgynecology. 32(1)
Purpose of review With a worldwide increase in obesity, there has been an increase in obesity-related diseases. Endometrial cancer is a common cause of cancer for women worldwide. Incidence of endometrial cancer has risen worldwide. Accompanying thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16fea55a69a1e4c42f55f9076817c189
https://pubmed.ncbi.nlm.nih.gov/31833943
https://pubmed.ncbi.nlm.nih.gov/31833943
Publikováno v:
Topics in Geriatric Rehabilitation. 32:210-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e79b873a6073298593231b0ee865b2ec
https://doi.org/10.1097/tgr.0000000000000112
https://doi.org/10.1097/tgr.0000000000000112
Publikováno v:
Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 21, Iss C, Pp 119-121 (2017)
Gynecologic Oncology Reports, Vol 21, Iss C, Pp 119-121 (2017)
Highlights • Extra-uterine endometrial stromal sarcoma may arise in endometriosis. • Abdominal exploration for extra pelvic endometriosis is warranted. • Representative endometriotic implants should be resected and/or biopsied if clinically sus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85c44a0c1d1fbf27478eedf7380f7b6
https://doi.org/10.1016/j.gore.2017.08.002
https://doi.org/10.1016/j.gore.2017.08.002
Autor:
Krishnansu S. Tewari, Juliet E Wolford
INTRODUCTION: Though cervical cytology, HPV DNA testing, and pre-invasive disease management has significantly reduced the number new diagnoses of cervical cancer, women with persistent oncogenic HPV variants are at significant risk for developing in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9fe2c68b235a3a9fac1b9a0e05a0db2
https://europepmc.org/articles/PMC6712992/
https://europepmc.org/articles/PMC6712992/
Autor:
Juliet E Wolford, Krishnansu S. Tewari
Publikováno v:
Journal of Gynecologic Oncology
Wolford, JE; & Tewari, KS. (2017). Highlights from the gynecologic oncology track at the 2017 Annual Meeting of the American Society of Clinical Oncology. JOURNAL OF GYNECOLOGIC ONCOLOGY, 28(5), e74. doi: 10.3802/jgo.2017.28.e74. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/7mz2b505
Wolford, JE; & Tewari, KS. (2017). Highlights from the gynecologic oncology track at the 2017 Annual Meeting of the American Society of Clinical Oncology. JOURNAL OF GYNECOLOGIC ONCOLOGY, 28(5), e74. doi: 10.3802/jgo.2017.28.e74. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/7mz2b505
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::600fc5fba761b49a1016840b25fd937f
https://doi.org/10.3802/jgo.2017.28.e74
https://doi.org/10.3802/jgo.2017.28.e74